Increased levels of antibiotic resistant bacteria in the environment may have different causes. It could be a consequence of on-site selection from antibiotic residues in the environment, hence promoting the evolution of new forms of resistance. Alternatively, it is simply due contamination by fecal bacteria that often tend to be more resistant than other bacteria. Understanding which explanation is correct is fundamental to manage risks.
A study published in Nature Communications shows that "crAssphage," a virus specific to bacteria in human feces, is highly correlated to the abundance of antibiotic resistance genes in environmental samples. This indicates that fecal pollution can largely explain the increase in resistant bacteria often found in human-impacted environments. There was, however, one clear exception where resistance genes were very common also without the presence of the phage -- environments polluted with high levels of antibiotics from manufacturing.
Joakim Larsson, professor in environmental pharmacology at Sahlgrenska Academy, University of Gothenburg, and one of the co-authors, notes, "These finding are important as they can inform management of human health risks associated with antibiotic resistant bacteria in the environment. While antibiotic residues is clearly the cause for the exceptionally high levels of resistance found near some manufacturing sites, fecal pollution is probably the explanation in most other places."
One may wonder if this means that we do not need to care about the low levels of antibiotics released from e.g. sewage treatment plants world-wide. Larsson comments "The study indicates the importance of taking into account the level of fecal pollution when interpreting findings of antibiotic resistance in the environment. It implicates that one often do not need to explain such findings by on-site selection from residual antibiotics. But it does not exclude that there still is selection by low levels of antibiotics in the environment going in in parallel. Other findings still suggest that low, environmental levels of certain antibiotics could select for resistance. This needs further research."
Source: University of Gothenburg
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.